Omesdafexor
N-[3-(1-cyclopropylpyrazol-4-yl)phenyl]-4-hydroxy-N-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]cyclohexane-1-carboxamide
Molecular Identity
Omesdafexor
N-[3-(1-cyclopropylpyrazol-4-yl)phenyl]-4-hydroxy-N-[[4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]cyclohexane-1-carboxamide
PubChem CID: 135329968
2D Structure
Properties
C34H43N3O3
Molecular Formula
541.70
Molecular Weight
g/mol
541.3304
Exact Mass
Da
6.1
XLogP
Above Lipinski threshold
67.6
TPSA
Good oral absorption (< 140 A²)
1
H-Bond Donors
4
H-Bond Acceptors
819
Complexity
SMILES
Canonical SMILES
SMILES: CC1=C(C=CC(=C1)C2CCC(CC2)CN(C3=CC=CC(=C3)C4=CN(N=C4)C5CC5)C(=O)C6CCC(CC6)O)OCIsomeric SMILES
SMILES: CC1=C(C=CC(=C1)C2CCC(CC2)CN(C3=CC=CC(=C3)C4=CN(N=C4)C5CC5)C(=O)C6CCC(CC6)O)OCSynonyms(20)
Omesdafexor2244440-85-3Omesdafexor [INN]E05WEZ4XLEtrans-N-(3-(1-Cyclopropyl-1H-pyrazol-4-yl)phenyl)-4-hydroxy-N-((trans-4-(4-methoxy-3-methylphenyl)cyclohexyl)methyl)cyclohexanecarboxamideCyclohexanecarboxamide, N-(3-(1-cyclopropyl-1H-pyrazol-4-yl)phenyl)-4-hydroxy-N-((trans-4-(4-methoxy-3-methylphenyl)cyclohexyl)methyl)-, trans-Cyclohexanecarboxamide, N-[3-(1-cyclopropyl-1H-pyrazol-4-yl)phenyl]-4-hydroxy-N-[[trans-4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]-, trans-trans-N-(3-(1-Cyclopropyl-1H-pyrazol-4-yl)phenyl)-4- hydroxy-N-((trans-4-(4-methoxy-3- methylphenyl)cyclohexyl)methyl)cyclohexane-1- carboxamidetrans-N-[3-(1-cyclopropyl-1H-pyrazol-4-yl)phenyl]-4- hydroxy-N-{[trans-4-(4-methoxy-3- methylphenyl)cyclohexyl]methyl}cyclohexane-1- carboxamidetrans-N-[3-(1-Cyclopropyl-1H-pyrazol-4-yl)phenyl]-4-hydroxy-N-[[trans-4-(4-methoxy-3-methylphenyl)cyclohexyl]methyl]cyclohexanecarboxamideUNII-E05WEZ4XLEMET642orb1686218CHEMBL5314434CHEMBL5831857
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Omesdafexor
Loading drug network...